A Difference Between Bedtime and Pre-Breakfast Plasma Glucose Levels Indicates the Need for Prandial Insulin in Basal Insulin-Treated Type 2 Diabetic Patients with Normal Fasting Glucose

AIM: In the present analysis, we characterised the efficacy and safety of adding a single daily injection of insulin glulisine to optimised basal-supported oral therapy (BOT) in patients with a high BeAM value, defined as a more than 50 mg/dl difference between bedtime and pre-breakfast blood glucos...

Descripción completa

Detalles Bibliográficos
Autores principales: Kress, Stephan, Borck, Anja, Zisman, Ariel, Bramlage, Peter, Siegmund, Thorsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987255/
https://www.ncbi.nlm.nih.gov/pubmed/33776458
http://dx.doi.org/10.2147/DMSO.S267882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987255/
https://www.ncbi.nlm.nih.gov/pubmed/33776458
http://dx.doi.org/10.2147/DMSO.S267882

Ejemplares similares